Preoperative assessment of liver function

Surgical Clinics of North America

Volumn 84, Issue 2, 2004, Pages 355-373

  Schneider, Philip D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYL HUMAN SERUM ALBUMIN; GALACTOSYLNEOGLYCOALBUMIN TC 99M; INDOCYANINE GREEN; SERUM ALBUMIN; TECHNETIUM 99M; UNCLASSIFIED DRUG;

BILE DUCT CARCINOMA; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER RESECTION; MEDICAL DECISION MAKING; PATIENT SELECTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK; SCINTIGRAPHY; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

COLORING AGENTS; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; PORTAL VEIN; RADIOPHARMACEUTICALS; RISK ASSESSMENT; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 1642414045     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(03)00224-X     Document Type: Review

References (49)

1. Akaki S, Mitsumori A, Kanazawa S, Togami I, Takeda Y. Lobar decrease in 99m-Tc-GSA accumulation in hilar cholangiocarcinoma. J Nucl Med 1999;40(3):394-8.
2. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85.
3. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
4. Reisman Y, Gip CH, Lavelle SM. Assessment of liver cirrhosis severity in 1015 patients of the Euricterus database with Campbell-Child, Pugh-Child and with ascites and ascitesnutritional state (ANS) related classifications. Euricterus Project Management Group. Hepatogastroenterology 1997;44(17):1376-84.
5. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F, et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990;98(3):733-8.
6. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987;205(1):33-40.
7. Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986;99(6):694-701.
8. Bismuth H, Houssin D, Ornowski J, Meriggi F. Liver resections in cirrhotic patients: a Western experience. World J Surg 1986;10(2):311-7.
9. Wheeler HO, Cranston WI, Meltzer JI. Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol Med 1958;99:236.
10. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960;39:592.
11. Okuchi O, Kaneko T, Sugimoto H, Inoue S, Takeda S, Nakao A. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 2002;103:109-13.
12. Nakajima K, Kinuya T, Mizutani Y, Hwang E-U, Michigishi T, Tonami N, Kobayashi K. Simple scintigraphic parameters with Tc-99m galactosyl human serum albumin for clinical staging of chronic hepatocellular dysfunction. Ann Nucl Med 1999;13(1):5-11.
13. Wakabayashi H, Okada S, Maeba T, Maeta H. Effect of preoperative portal vein embolization on major hepatectomy for advnced-stage hepatocellular carcinomas in injured livers: a preliminary report. Jpn J Surg 1997;27:403-10.
14. Nakano H, Yoshida K, Takeuchi S, Kumada K, Yamaguchi M, Jaeck D. Liver scintigraphy is useful for selecting candidates for preoperative transarterial chemoembolization among patients with hepatocellular carcinoma and chronic liver disease. Am J Surg 1999;178(11):385-9.
15. Lam CM, Fan ST, Lo CM, Wong J. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 1999;86(8):1012-7.
16. Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989;24(3):269-76.
17. Ashwell G, SC. Hepatic recognition and catabolism of serum glycoprotein. JAMA 1981;246:2358-64.
18. Eckelman WC, Reba RC, Gibson RE, Rzeszotarski WJ, Vieras F, Mazaitis JK, et al. Receptor-binding radiotracers: a class of potential radiopharmaceuticals. J Nucl Med 1979;20(4):350-7.
19. Pimstone NR Sr, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocelllular function by way of receptor-mediated uptake of a technetium-99m-labelled asialoglycoprotein analog. Hepatology 1994;20(4):917-23.
20. Stadalnik RC, Vera DR, Woodle ES, Trudeau WL, Ward RE, Krohn KA. Technetium-99m-NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med 1985;26:1233-42.
21. Vera DR, Stadalnik RC, Krohn KA. (Tc-99m)-galactosyl-neoglycoalbumin: preparation and preclinical studies. J Nucl Med 1985;26:1157-67.
22. Kudo M, Todo A, Ikekubo K, Hino M, Yonekura Y, Yamamoto K, et al. Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass. Gastroenterol Jpn 1991;26(6):734-41.
23. Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, et al. Clinical usefulness of scintigraphy with 99m-Tc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med 1999;40(10):1652-6.
24. Kwon A-H, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 1995;117(4):429-34.
25. Ha-Kawa SK, Tanaka Y, Hasebe S, Kuniyasu Y, Koizumi K, Ishii Y, et al. Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med 1997;24(2):130-7.
26. Hwang E-H, Taki J, Shuke N, Nakajima K, Kinuya S, Konishi S, Michigishi T, et al. Preoperative assessment of residual hepatic functional reserve using 99m-Tc-DTPAgalactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999;40(10):1644-51.
27. Harada H, Imamura H, Miyagawa S, Kawasaki S. Fate of the human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study. Hepatology 1997;26(5):1162-9.
28. Tanaka A, Shinohara H, Hatono E, Sato S, Kanazawa A, Yamaoka Y, Torizuka T, et al. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium 99m galactosyl human serum albumin. Hepatogastroenterology 1999;46:369-75.
29. Kokudo N, Vera DR, Koizumi M, Seki M, Sato T, Stadalnik RC, Takahashi T. Recovery of hepatic asialoglycoprotein receptors after major hepatic resection. J Nucl Med 1998;40(1):137-41.
30. Fujioka H, Kawashita Y, Kamohara Y, Yamashita A, Mizoe A, Yamaguchi J, Azuma T, et al. Utility of technetium-99m0labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic function reserve. J Clin Gastroenterol 1999;28(4):329-33.
31. Uetake M, Koizumi K, Yagawa A, Nogata H, Tezuka T, Kono H, Ozawa T, et al. Use of Tc-99m DTPA galactosyl human serum albumin to predict postoperative residual liver function. Clin Nucl Med 1999;24(6):428-34.
32. Wakabayashi H, Nishiyama Y, Ushiyama T, Maeba T, Maeta H. Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry. J Surg Res 2002;106:246-53.
33. Kubo S, Shiomi S, Tanaka H, Shuto T, Takemura S, Mikami S, Uenishi T, et al. Evaluation of the effect of portal vein embolization on liver function by 99m-Tc-glactosyl human serum albumin scintigraphy. J Surg Res 2002;107:113-8.
34. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, et al. Nomortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134(9):984-92.
35. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 2002;236(5):602-11.
36. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236(4):397-406 [discussion: 406-7].
37. Redaelli CA, Wagner M, Krahenbuhl L, Gloor B, Schilling MK, Dufour J-F, Buchler MW. Liver surgery in the era of tissue-preserving resections: early and late outcome in patients with primary and secondary hepatic tumors. World J Surg 2002;26:1126-32.
38. Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K. Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 1984;199(1):51-6.
39. Lee CS, Sung JL, Hwang LY, Sheu JC, Chen DS, Lin TY, et al. Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery 1986;99(4):481-90.
40. Tsao JI, Asbun HJ, Hughes KS, Abaubara S, August DA, Azurin A, et al. Hepatoma registry of the Western world. Repeat Hepatic Resection Registry. Cancer Treat Res 1994;69:21-31.
41. Arii S, Okamoto E, Imamura M. Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan. Semin Surg Oncol 1996;12(3):204-11.
42. loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 1999;46(27):1669-72.
43. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986;73(9):727-31.
44. Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987;205(3):256-63.
45. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991;78(7):797-801.
46. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F, et al. Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 1995;82(3):377-81.
47. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77(7):1254-62.
48. Fortner JG, Silva JS, Bolbey RB, Cox EB, Maclean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984;199:306-16.
49. Iwatsuki S, Esquivel CO, Gordon RD, Starzl TE. Liver resection for metastases from colorectal cancer. I. Surgery 1984;199:306-16.